The purpose of this research is to find out whether the investigational drug IMA203 is an effective and safe treatment for patients with cutaneous melanoma (i.e. skin cancer) that is growing or has returned after prior standard treatment.
Thank you for your interest, but this study will start enrolling soon.
North Carolina (Statewide)
Stergios Moschos
LCCC - Clinical Trials
Clinical or Medical
Interventional
Cancer (Melanoma)
24-2682
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
